Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

NCT06201741 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT06201741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06201741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 27, 2023
Completion date
June 30, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate specific membrane antigen positive metastatic prostate cancer